— Know what they know.
Not Investment Advice

CBUS NASDAQ

Cibus, Inc.
1W: +12.5% 1M: +9.6% 3M: +21.3% YTD: -9.0% 1Y: +27.6% 3Y: -90.7% 5Y: -99.0%
$1.71
+0.08 (+4.91%)
 
Weekly Expected Move ±8.3%
$1 $2 $2 $2 $2
NASDAQ · Healthcare · Biotechnology · Tech Score Neutral · Power 48 · $130.5M mcap · 47M float · 0.529% daily turnover · Short 65% of daily vol

Revenue Segmentation

By Product / Service

Revenue by Segment (5-Year Trend)

Income Trends

Revenue
$4M -14.6% ▼
5Y CAGR: -31.3%
Gross Profit
-$2M -153.6% ▼
Operating Income
-$67M +73.9% ▲
Net Income
-$127M +49.4% ▲
EPS (Diluted)
$-2.78 +74.3% ▲
EBITDA
-$62M +74.5% ▲

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
Revenue$26M$157K$2M$4M$4M
YoY Growth+9.0%-99.4%+1057.3%+134.6%-14.6%
Cost of Revenue$29M$2M$395K$0$6M
Gross Profit-$3M-$1M$1M$4M-$2M
Gross Margin-9.9%-877.1%78.3%100.0%-62.8%
R&D Expenses$11M$12M$42M$50M$44M
SG&A Expenses$15M$9M$29M$31M$27M
Operating Expenses$27M$21M$320M$263M$65M
Operating Income-$29M-$22M-$319M-$258M-$67M
Operating Margin-112.9%-14248.4%-17550.0%-6062.8%-1853.9%
Interest Expense$1M$87K$19M$34M$35M
Income Before Tax-$29M-$17M-$338M-$283M-$132M
Tax Expense$0$0-$4K$29K$29K
Net Income-$29M-$17M-$268M-$251M-$127M
Net Margin-112.4%-10758.6%-14729.1%-5898.4%-3492.3%
EPS (Diluted)$-0.05$-0.03$-25.95$-10.83$-2.78
EBITDA-$25M-$15M-$315M-$242M-$62M
Shares Outstanding578M578M10M23M458M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms